Barclays’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-113,303
| Closed | -$1.27M | – | 4342 |
|
|
2017
Q3 | $1.27M | Buy |
113,303
+28,348
| +33% | +$317K | ﹤0.01% | 1454 |
|
|
2017
Q2 | $934K | Buy |
84,955
+2,731
| +3% | +$30K | ﹤0.01% | 1601 |
|
|
2017
Q1 | $806K | Sell |
82,224
-59,906
| -42% | -$587K | ﹤0.01% | 1688 |
|
|
2016
Q4 | $1.53M | Buy |
142,130
+54,633
| +62% | +$590K | ﹤0.01% | 1275 |
|
|
2016
Q3 | $897K | Sell |
87,497
-3,965
| -4% | -$40.6K | ﹤0.01% | 1469 |
|
|
2016
Q2 | $1.19M | Buy |
91,462
+6,086
| +7% | +$79.5K | ﹤0.01% | 1363 |
|
|
2016
Q1 | $939K | Buy |
85,376
+60,822
| +248% | +$669K | ﹤0.01% | 1423 |
|
|
2015
Q4 | $221K | Sell |
24,554
-12,133
| -33% | -$109K | ﹤0.01% | 1999 |
|
|
2015
Q3 | $220K | Buy |
36,687
+35,680
| +3,543% | +$214K | ﹤0.01% | 2087 |
|
|
2015
Q2 | $10K | Sell |
1,007
-13,283
| -93% | -$132K | ﹤0.01% | 3319 |
|
|
2015
Q1 | $114K | Sell |
14,290
-3,369
| -19% | -$26.9K | ﹤0.01% | 2462 |
|
|
2014
Q4 | $141K | Buy |
17,659
+9,976
| +130% | +$79.7K | ﹤0.01% | 2520 |
|
|
2014
Q3 | $45K | Sell |
7,683
-24,495
| -76% | -$143K | ﹤0.01% | 3055 |
|
|
2014
Q2 | $161K | Sell |
32,178
-1,564
| -5% | -$7.83K | ﹤0.01% | 2498 |
|
|
2014
Q1 | $135K | Buy |
33,742
+20,467
| +154% | +$81.9K | ﹤0.01% | 2598 |
|
|
2013
Q4 | $66K | Sell |
13,275
-3,966
| -23% | -$19.7K | ﹤0.01% | 3256 |
|
|
2013
Q3 | $86K | Buy |
17,241
+6,617
| +62% | +$33K | ﹤0.01% | 3015 |
|
|
2013
Q2 | $53K | Buy |
+10,624
| New | +$53K | ﹤0.01% | 3321 |
|